Frank Joseph Daugherty - 24 Dec 2024 Form 4 Insider Report for Greenwich LifeSciences, Inc. (GLSI)

Role: Chief Medical Officer, Director
Signature: /s/ Frank Daugherty
Issuer symbol: GLSI
Transactions as of: 24 Dec 2024
Net transactions value: $0
Form type: 4
Filing time: 27 Dec 2024, 16:19:46 UTC
Previous filing: 24 Jun 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GLSI	Stock Options	Award	$0	+104,890	+100%	$0.000000	209,780	24 Dec 2024	Common Stock	104,890	$12.16	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	26,233 options are earned upon date of grant and the remainder are earned monthly over 36 months. 10% of the earned options vest if reporting person has been employed by Issuer between 1-2 years from grant date, 20% of the earned options vest if reporting person has been employed by Issuer between 2-3 years from grant date, 30% of the earned options vest if reporting person has been employed by Issuer between 3-4 years from grant date and the remaining earned options vest if reporting person has been employed by Issuer more than 4 years after grant date.

Content

26,233 options are earned upon date of grant and the remainder are earned monthly over 36 months. 10% of the earned options vest if reporting person has been employed by Issuer between 1-2 years from grant date, 20% of the earned options vest if reporting person has been employed by Issuer between 2-3 years from grant date, 30% of the earned options vest if reporting person has been employed by Issuer between 3-4 years from grant date and the remaining earned options vest if reporting person has been employed by Issuer more than 4 years after grant date.